EP 1466012 A2 20041013 - NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH OSTEOPOROSIS
Title (en)
NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH OSTEOPOROSIS
Title (de)
MIT OSTEOPOROSE ASSOZIIERTE NUKLEOTIDPOLYMORPHISMEN
Title (fr)
POLYMORPHISMES NUCLEOTIDIQUES ASSOCIES A L'OSTEOPOROSE
Publication
Application
Priority
- US 0240948 W 20021219
- US 34271101 P 20011220
- US 42355902 P 20021104
Abstract (en)
[origin: WO03054218A2] The invention relates to polynucleotides associated with susceptibility to low bone mineral density and/or bone damage generally associated with human diseases, and in particular to osteoporosis. The invention further relates to polymorphic polynucleotides associated with osteoporosis. The invention provides methods of determining if a particular polymorphism predisposes an individual to or is associated with the development of osteoporosis. The invention also provides methods of detecting the presence of one or more polymorphism as an indicator of osteoporosis, and provides for use of novel polynucleotides of the invention in the development of drugs and in disease treatment.
IPC 1-7
IPC 8 full level
C12Q 1/68 (2006.01)
IPC 8 main group level
C12Q (2006.01)
CPC (source: EP)
C12Q 1/6883 (2013.01); C12Q 2600/156 (2013.01)
Citation (search report)
See references of WO 03054218A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 03054218 A2 20030703; WO 03054218 A3 20040219; AU 2002366709 A1 20030709; AU 2002366709 A8 20030709; CA 2471376 A1 20030703; EP 1466012 A2 20041013
DOCDB simple family (application)
US 0240948 W 20021219; AU 2002366709 A 20021219; CA 2471376 A 20021219; EP 02805650 A 20021219